BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ)
$3.37 -0.1 (-2.8818%)
Analysed BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) News Sources
BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
26-03-2026
yahoo.com
Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma
08-04-2026
yahoo.com
BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
28-04-2026
yahoo.com
BioLineRx and Hemispherian Announce New GLIX1 Data Demonstrating Potent Anti-Tumor Effect in Glioblastoma (GBM) Across Multiple In-Vivo Studies, Including a Temozolomide (TMZ)-Resistant Model with Patient-Derived Xenografts
19-05-2026
yahoo.com
BioLineRx to Report First Quarter 2026 Results on May 27, 2026
20-05-2026
yahoo.com
BioLineRx and Hemispherian AS Highlight New Data on GLIX1 at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
22-05-2026
yahoo.com
BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
27-05-2026
yahoo.com
BioLineRx Shares Advance After First Patient Enrolled in GLIX1 Cancer Study (BLRX)
27-05-2026
advfn.com
BLRX: First Quarter 2026 Results
28-05-2026
yahoo.com
BioLine Rx Ltd (BLRX) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...
03-06-2026
yahoo.com
What is the current price of BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ)?
The current price of BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) is $3.37.
BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) since the previous trading day is $-0.1.
BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) since the previous trading day is -2.8818%.
What is the most recent average sentiment score for BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ)?
The most recent average sentiment score for BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ)?
The most recent sentiment for BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) is .
SEC-8K** Filing Available For BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.